Abstract:Background: To investigate the prognostic significance of systemic inflammation score (SIS) in upper tract urothelial carcinoma (UTUC) in patients undergoing radical nephroureterectomy (RNU). Methods: A total of 313 UTUC patients who underwent RNU at West China Hospital from May 2014 to June 2019 were retrospectively analyzed. The predictive value of SIS for relevant endpoints, including overall survival (OS), cancer-specific survival (CSS), and progression-free survival (PFS), was assessed by Kaplan–Meier curves and the Cox proportional hazards model. Results: According to inclusion and exclusion criteria, 218 UTUC patients were ultimately included in this cohort study. Statistical analysis shows that increased SIS was significantly associated with higher TNM stage (p = 0.017), lower BMI (p = 0.037), absence of hemoglobin (p < 0.001), and pathologic necrosis (p = 0.007). Kaplan–Meier survival curves clearly visually stratified survival for the three outcomes. After adjusting for tumor grade, the multivariate Cox proportional hazards model results showed that SIS was an independent risk factor for poor OS and CSS (HR = 1.89, 95% CI: 1.11–3.21, p = 0.0183, HR = 1.89, 95% CI: 1.07–3.33, p = 0.0285) in the advanced group. Conclusions: SIS was an independent risk factor for OS and CSS after RNU in patients with high-grade UTUC. It may be a novel and conducive tool for preoperative risk stratification and guiding individualized therapy for high-risk UTUC patients.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the prognostic significance of the Systemic Inflammation Score (SIS) before radical nephroureterectomy (RNU) in patients with Upper Tract Urothelial Carcinoma (UTUC). Specifically, the study aims to evaluate the predictive value of SIS for Overall Survival (OS), Cancer - Specific Survival (CSS) and Progression - Free Survival (PFS). ### Research Background - **Disease Characteristics**: Upper tract urothelial carcinoma is relatively rare, but about two - thirds of patients are already at the invasive disease stage at the time of diagnosis and have a relatively high recurrence rate. - **Treatment Status**: Radical nephroureterectomy is currently the gold standard for the treatment of UTUC, but the prognosis of patients is still poor. - **Association between Inflammation and Prognosis**: The nutritional and inflammatory status has a significant impact on the prognosis of cancer patients. Multiple studies have shown that inflammation - related biomarkers can be used as prognostic factors. ### Research Objectives - **Primary Objective**: To evaluate the prognostic value of SIS in patients with UTUC, especially for high - risk patients, whether SIS can be used as an independent risk - stratification tool to guide individualized treatment. - **Specific Questions**: - Is SIS significantly associated with OS, CSS and PFS in patients with UTUC? - Can SIS be used as a prognostic indicator for high - risk UTUC patients? ### Methods - **Research Design**: Retrospective cohort study. - **Sample Selection**: Among 313 UTUC patients who underwent RNU in West China Hospital of Sichuan University from May 2014 to June 2019, 218 patients were finally selected for analysis according to the inclusion and exclusion criteria. - **SIS Definition**: Combining the serum albumin level and the Lymphocyte - to - Monocyte Ratio (LMR), SIS is divided into a low - risk group and a high - risk group. - **Statistical Analysis**: Kaplan - Meier survival curves and Cox proportional - hazards models were used to evaluate the impact of SIS on OS, CSS and PFS. ### Results - **Baseline Characteristics**: Among the 218 patients, 76 were classified into the high - SIS group and 142 were classified into the low - SIS group. Patients in the high - SIS group had a higher TNM stage, a lower BMI, were more likely to lack hemoglobin and had more common pathological necrosis. - **Survival Analysis**: Kaplan - Meier survival curves showed that the OS, CSS and PFS of patients in the high - SIS group were all significantly worse. Multivariate Cox regression analysis showed that after adjusting for tumor grade, SIS was an independent risk factor for OS and CSS in high - risk group patients (HR = 1.89, 95% CI: 1.11–3.21, p = 0.0183; HR = 1.89, 95% CI: 1.07–3.33, p = 0.0285). ### Conclusions - **Main Conclusions**: SIS is an independent prognostic factor for OS and CSS in high - risk UTUC patients after radical nephroureterectomy. SIS may become a new tool that is helpful for preoperative risk - stratification and guiding individualized treatment. ### Significance - **Clinical Application**: If SIS can be used as a predictive model, it can more conveniently predict the prognosis of patients at an early stage, so as to implement medical interventions in advance and prolong the survival time of patients. - **Future Research Directions**: More large - sample and prospective studies are needed to further verify this conclusion.

Preoperative Systemic Inflammation Score Predicts the Prognosis of Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy

The Predictive Value of Systemic Immune-Inflammation Index on Bladder Recurrence on Upper Tract Urothelial Carcinoma Outcomes after Radical Nephroureterectomy

Analysis of preoperative nutrition, immunity and inflammation correlation index on the prognosis of upper tract urothelial carcinoma surgical patients: a retrospective single center study

Prognostic and clinicopathological significance of systemic immune-inflammation index in upper tract urothelial carcinoma: a meta-analysis of 3911 patients

Prognostic models for upper urinary tract urothelial carcinoma patients after radical nephroureterectomy based on a novel systemic immune-inflammation score with machine learning

Systemic Inflammation Score Predicts Postoperative Prognosis of Patients with Clear-Cell Renal Cell Carcinoma

Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival in Patients with Localized Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy

The Preoperative Serum Cystatin-C As an Independent Prognostic Factor for Survival in Upper Tract Urothelial Carcinoma

Preoperative Risk Classification Using Neutrophil-to-Lymphocyte Ratio and Albumin for Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy.

A dynamic nomogram integrated with blood inflammation markers for predicting overall survival in patients with upper tract urothelial carcinoma

Prognostic and clinical pathological significance of the systemic immune-inflammation index in urothelial carcinoma: a systematic review and meta-analysis

Influence of American Society of Anesthesiologists Score on Oncologic Outcomes in Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy: A Large-Sample Study in Two Institutions

Systemic Immune-Inflammation Index Predicts Prognosis of Bladder Cancer Patients after Radical Cystectomy

Preoperative Hydronephrosis Predicts Adverse Pathological Features and Postoperative Survival in Patients with High-Grade Upper Tract Urothelial Carcinoma.

Survival and risk factors among upper tract urothelial carcinoma patients after radical nephroureterectomy in Northeast China

Preoperative Plasma Insulin-Like Growth Factor-I and Its Binding Proteins-Based Risk Stratification of Patients Treated With Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma

The Prognostic Value of Preoperative Neutrophil-to-lymphocyte Ratio in Patients with Upper Tract Urothelial Carcinoma

Preoperative Pyuria Predicts Advanced Pathologic Tumor Stage and Worse Survival in Patients with Urothelial Carcinoma of the Upper Urinary Tract Treated by Radical Nephroureterectomy

A Simplified Frailty Index and Nomogram to Predict the Postoperative Complications and Survival in Older Patients with Upper Urinary Tract Urothelial Carcinoma

Usefulness of Preoperative High Systemic Immune-Inflammation Index as a Prognostic Biomarker in Patients Who Undergo Radical Cystectomy for Bladder Cancer: Multicenter Analysis

Validation of the Pretreatment Neutrophil-to-Lymphocyte Ratio As a Prognostic Factor in a Large Cohort of Chinese Patients with Upper Tract Urothelial Carcinoma